Signet Therapeutics

Signet Therapeutics is an artificial intelligence company in Boston, United States, founded in 2020. It has raised $21.5M across 2 rounds, most recently an $11.5M Series A in January 2026.

Organoid-Driven AI-Powered Drug Development

Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$21.5M
Last Round
$11.5M Series AJan 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Signet Therapeutics develops targeted cancer therapies using organoids and artificial intelligence. Its work as a clinical-stage biotechnology business focuses on pioneering first-in-class treatments, combining organoids with AI in an approach directed toward the development of new targeted therapies for cancer.

Summary

It lists 11–50 employees. It has raised $21.5M in total across 2 rounds, most recently a $11.5M Series A round in Jan 2026. Investors include Tiantu Capital, 5Y Capital and Green Pine Capital Partners.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AJan 2026
$11.5M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series CTotal funding$2.6BNov 2026
OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate RoundTotal funding$179.6BMar 2026
Anthropic

Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...

San Francisco, United States1001–5000Artificial Intelligence, Generative AI
Series G+Total funding$123.7BMay 2026
xAI

xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...

San Francisco, United States201–500Artificial Intelligence, Generative AI
Series ETotal funding$47.4BJan 2026
Waymo

Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...

Mountain View, United States1001–5000Artificial Intelligence, Autonomous Vehicles
Venture RoundTotal funding$29.6BFeb 2026
Databricks

Databricks provides a unified data and AI platform that helps enterprises build and run applicati...

San Francisco, United States10001+Analytics, Artificial Intelligence
Series G+Total funding$20.0BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Signet Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/signet-therapeutics"><img src="https://indexed.vc/api/badge/company/signet-therapeutics" alt="Signet Therapeutics on Indexed.vc" width="260" height="76" /></a>